Start for free
Start for free
Viking Global Investors logo

Viking Global Investors

North America, Connecticut, United States, Stamford

Description

Viking Global Investors is an investment firm that uses fundamental analysis to select investments across industries and geographies.

Investor Profile

Viking Global Investors has made 168 investments, with 9 in the past 12 months and 36% as lead.

Stage Focus

  • Series B (21%)
  • Series A (18%)
  • Series C (13%)
  • Series D (10%)
  • Series E (8%)
  • Private Equity (7%)
  • Series Unknown (6%)
  • Seed (5%)
  • Post Ipo Equity (4%)
  • Series F (2%)

Country Focus

  • United States (86%)
  • Canada (4%)
  • United Kingdom (4%)
  • China (1%)
  • Mexico (1%)
  • Brazil (1%)
  • Switzerland (1%)
  • Ireland (1%)
  • Israel (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Biopharma
  • Software
  • Life Science
  • Saas
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Viking Global Investors frequently co-invest with?

OrbiMed
OrbiMed
North America, New York, United States, New York
Co-Investments: 14
Wellington Management
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 11
CA
Cormorant Asset Management
North America, Massachusetts, United States, Boston
Co-Investments: 16
Casdin Capital
Casdin Capital
North America, New York, United States, New York
Co-Investments: 12
T. Rowe Price
T. Rowe Price
North America, Maryland, United States, Baltimore
Co-Investments: 12
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 15
Perceptive Advisors
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 21
Logos Capital
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 11
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 10
Fidelity
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 10

Which angels does Viking Global Investors often collaborate with?

KP
Katy Perry
North America, California, United States, Los Angeles
Shared Deals: 4
AK
Ahmir Khalib Thompson
North America, Pennsylvania, United States, Philadelphia
Shared Deals: 2
BG
Bill Gates
North America, Washington, United States, Seattle
Shared Deals: 4
PG
Paul George
North America, California, United States, Los Angeles
Shared Deals: 2
AO
Alexis Ohanian
North America, California, United States, San Francisco
Shared Deals: 2
KC
Kirk Cousins
North America, Minnesota, United States
Shared Deals: 2
PR
Philip Rosenthal
North America, California, United States, Los Angeles
Shared Deals: 2
JS
Jaden Smith
North America, New York, United States, New York
Shared Deals: 2
AZ
Anton Zaslavski
North America, California, United States, Los Angeles
Shared Deals: 2
Kal Penn
Shared Deals: 2

What are some of recent deals done by Viking Global Investors?

ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityMay 28, 2025
Amount Raised: $125,000,000
AssetWatch

Westerville, Ohio, United States

AssetWatch is a deployable, remote, end-to-end condition monitoring solution providing predictive insight to enable proactive maintenance.

Big DataIndustrial AutomationInternet of ThingsMachine LearningPredictive Analytics
Series CApr 30, 2025
Amount Raised: $75,000,000

Nova Anchora is a biopharmaceutical company advancing a corrective protein therapy for DEB, a severe rare skin disease

Biotechnology
Series UnknownApr 29, 2025
Canopy

Draper, Utah, United States

Canopy offers a cloud-based Practice Management solution for Accounting professionals.

AccountingBillingCRMDocument ManagementPaymentsProject ManagementSoftware
Series CApr 23, 2025
Amount Raised: $70,000,000
Neurona Therapeutics

San Francisco, California, United States

Neurona Therapeutics develops cell therapies for neurological disorders, focusing on treatments like NRTX-1001 for epilepsy.

BiotechnologyHealth CareTherapeutics
Series FApr 3, 2025
Amount Raised: $102,000,000
Valsoft

Montréal, Quebec, Canada

Valsoft specializes in the acquisition and growth of vertical-market software enterprises.

Business DevelopmentSoftware
Private EquityDec 26, 2024
Amount Raised: $150,000,000
Metsera

New York, New York, United States

Metsera is a biopharmaceutical company that develops medicines for obesity and metabolic diseases.

BiopharmaHealth CareMedicalPharmaceutical
Series BNov 13, 2024
Amount Raised: $215,000,000
Triveni Bio

Watertown, Massachusetts, United States

Triveni Bio is a a biotech company that develops functional antibodies targeting immunological and inflammatory disorders.

BiotechnologyHealth CareMedicalTherapeutics
Series BOct 2, 2024
Amount Raised: $115,000,000
Humaneva

Raleigh, North Carolina, United States

Humaneva is a healthacare research company that offers reliable clinical research data that empowers the medical community.

Clinical TrialsHealth CareOutpatient Care
Private EquitySep 24, 2024
Amount Raised: $50,000,000

GondolaBio researches, develops and manufactures pharmaceutical products.

ManufacturingPharmaceutical
Series UnknownAug 16, 2024
Amount Raised: $300,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator